Related Experiment Video
Updated: Sep 3, 2025
06:40
Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
Published on: February 23, 2024
1.4K
TargetMine 2022: a new vision into drug target analysis
Yi-An Chen1, Rodolfo S Allendes Osorio1, Kenji Mizuguchi1,2
1Artificial Intelligence Center for Health and Biomedical Research (ArCHER), National Institutes of Biomedical Innovation, Health and Nutrition, Osaka 567-0085, Japan.
Bioinformatics (Oxford, England)
|July 27, 2022
Summary
The updated TargetMine platform now offers enhanced visualization options and integrated functionalities. This bioinformatics tool is accessible online and its source code is publicly available for research use.
Area of Science:
- Bioinformatics
- Computational Biology
- Data Visualization
Background:
- TargetMine is a data integration and visualization platform for biological targets.
- Previous versions had disaggregated functionalities and limited visualization options.
Purpose of the Study:
- To introduce the newest version of TargetMine.
- To highlight improvements in visualization and functionality integration.
- To announce the migration to the Bluegenes service.
Main Methods:
- Integration of previously disaggregated functionalities.
- Migration of the front-end to the Bluegenes service.
- Addition of new visualization options.
Main Results:
- The new TargetMine version offers enhanced visualization capabilities.
- Functionalities are now integrated, improving user experience.
- The platform is now hosted on the Bluegenes service.
Conclusions:
- The updated TargetMine provides a more powerful and user-friendly platform for exploring biological target data.
- The integration and enhanced visualization facilitate deeper biological insights.
- The availability of source code promotes collaborative research in bioinformatics.
More Related Videos
Related Concept Videos
01:26Drug Discovery: Overview
8.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.6K
01:26Targets for Drug Action: Overview
7.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.3K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K